Author Topic: (Abst.) Shorter infusion time of ocrelizumab...  (Read 82 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Shorter infusion time of ocrelizumab...
« on: October 12, 2020, 03:25:24 pm »
From PubMed (October 12, 2020), "Shorter infusion time of ocrelizumab: Results from the randomized, double-blind ENSEMBLE PLUS substudy in patients with relapsing-remitting multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/33039944/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
FDA approves shorter infusion time for Ocrevus
« Reply #1 on: December 14, 2020, 08:51:59 pm »
This should be good news for anyone using Ocrevus. The FDA has approved a 2-hour twice-yearly infusion time for Ocrevus, which has involved a 3.5-hour infusion time twice a year.


https://www.gene.com/media/press-releases/14890/2020-12-14/fda-approves-genentechs-ocrevus-ocrelizu
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
2 Replies
465 Views
Last post December 26, 2016, 02:47:31 pm
by agate
0 Replies
191 Views
Last post January 25, 2018, 04:31:23 pm
by agate
0 Replies
86 Views
Last post April 20, 2020, 08:29:55 am
by agate
0 Replies
62 Views
Last post June 01, 2020, 09:12:14 pm
by agate
0 Replies
4 Views
Last post February 28, 2024, 09:20:32 pm
by agate